ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022

Advanced Prostate Cancer Clinical Trials Update 2022Подробнее

GU ASCO Symposium 2022 SummaryПодробнее

Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022Подробнее

Highlights in prostate cancer from ESMOПодробнее

ESMO Expert Report on antibody drug conjugates in the management of urothelial cancer @ASCO GU 2022Подробнее

Expert Video Report on castration sensitive and resistant prostate cancer - 2021 ASCO Annual MeetingПодробнее

Expert Report on latest data in the management of metastatic prostate cancer from ASCO 2022Подробнее

Combination therapy for patients with prostate cancerПодробнее

#ESMO22 Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HDПодробнее

ESMO 2021: Updates in hormone-sensitive prostate cancerПодробнее

ASCO 2023 Expert Report on novelties in oncogene driven NSCLC by A. Curioni-FontecedroПодробнее

Upcoming GU cancer trials to be presented at ESMO 2022Подробнее

ESMO 2020 Expert Video Report on precision medicine in prostate cancerПодробнее

#ESMO21 Expert Video Report on Prostate cancerПодробнее

Highlights from ASCO GU 2022Подробнее

Clinical trial updates in prostate cancer at ESMO 2022Подробнее

Expert Report on panitumumab for first line treatment of RAS wild type mCRC from ASCO 2022Подробнее

ESOU Online: EAU22 highlights in prostate cancerПодробнее

Expert video report on Prostate Cancer from 2021 Genitourinary Cancers SymposiumПодробнее